Prospective Study
Copyright ©The Author(s) 2017.
World J Gastrointest Endosc. Mar 16, 2017; 9(3): 133-138
Published online Mar 16, 2017. doi: 10.4253/wjge.v9.i3.133
Table 1 Patient and procedure data for Phases 1 and 2 n (%)
Phase 1(n = 55)Phase 2(n = 116)
Indications for colonoscopy1
Surveillance38 (69)85 (73)
Screening12 (21.8)29 (25)
Abdominal pain/diarrhea8 (14.5)11 (9.5)
Bleeding6 (10.9)7 (6)
Change in bowel habits2 (3.6)2 (1.7)
Evaluation/therapy of known lesions1 (1.8)2 (1.7)
Anemia3 (5.5)2 (1.7)
Abnormal imagingN/A2 (1.7)
Other1 (1.8): Diverticulitis3 (2.6): Diverticulitis: 1 Rectal prolapse: 1 Rectal pain: 1
Patient characteristics
Male/female (n)36/1965/51
Mean age (Range)69.3 (37-87)65.5 (29-87)
Family history of colon cancer12 (21.8)27 (23.3)
Procedure data and outcomes
Total colonoscopies21212464
Total polyps65151
Polyp size (cm): (Mean ± SD, median, range)2 ± 0.69, 2, 1.2-41.81 ± 0.54, 1.6, 1.2-4
Clips/polyp (Mean ± SD, median)N/A2.17 + 0.97, 2
Polypectomy duration (min): Mean (SD), median, range18.69 (15.31), 18, 2-6116.4 (10.04), 13, 4-592
Procedure duration (min): Mean (SD), median, range44.70 (18.83), 41, 14-9742.90 (15.60), 40, 20-96
Prevalence of large, flat right- sided polyps3.8% (81/2121 procedures)6.3% (154/2464 procedures)
ComplicationsPost-polypectomy bleeds: 0 Perforations: 2 3.6% of patients, 3% of polypectomiesPost-polypectomy bleeds: 0 Perforations: 0
Table 2 Polyp histopathology n (%)
Phase 11 (n = 65)Phase 2 (n = 151)
Sessile serrated adenoma16 (25.0)68 (45.0)
Tubular adenoma31 (48.0)47 (31.0)
Hyperplastic10 (15.0)24 (16.0)
Tubulovillous7 (11.0)7 (5.0)
Normal1 (1.5)2 (1.3)
Fibroepithelial1 (1.5)N/A
LipomaN/A2 (1.3)
Pneumatosis coliN/A1 (0.7)